Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Genetics may play a significant role in gender dysphoria.

Gender-affirming care greatly improves mental health for transgender and non-binary individuals.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.